Lynn Malec – The New Director of the CCBD and Pharmacy at Children’s Wisconsin
Versiti Inc shared on LinkedIn:
”Versiti is proud to announce the promotion of Lynn Malec, MD, MSc, to Program Director of the Comprehensive Center for Bleeding Disorders (CCBD) and Pharmacy at Children’s Wisconsin.
Since joining Versiti in 2016, Dr. Malec has led transformative advances in bleeding disorder care, including launching our gene therapy program for hemophilia B, which made Versiti one of the first centers in the U.S. to administer the FDA-approved therapy HEMGENIX.
Her internationally recognized research and compassionate leadership continue to expand access to breakthrough treatments and whole-person care for patients and families.
Learn more about our commitment to advancing hope through science.”
More winner stories featured in Hemostasis Today.
-
Apr 2, 2026, 16:20Veronica Sanchez: Know Stroke Signs and Act Fast
-
Apr 2, 2026, 16:08Ney Carter Borges: Early Surgery vs Conservative Care in Asymptomatic Very Severe Aortic Stenosis
-
Apr 2, 2026, 15:52Gevorg Yaghjyan: How Yale is Redefining Bladder Cancer Treatment Through Strategy Focused Trials
-
Apr 2, 2026, 15:10Webinar on the Role of Omega-3 Fatty Acids in Cardiovascular Health – EAS
-
Apr 2, 2026, 15:06Leonardo Roever: Atherofrailty Score Offers a A Novel Machine Learning Approach to Stroke Risk Stratification
-
Apr 2, 2026, 14:55André da Silva: Stroke Is Not an Explosion – It’s Often a Silent Loss of Blood Flow
-
Apr 2, 2026, 14:39Maria Τektonidou: STAT1 as a Potential Therapeutic Target in Thrombotic Antiphospholipid Syndrome
-
Apr 2, 2026, 14:18Deise Catamo Vaz: WSO Future Stroke Leaders Project Offers A Closing for Large Information Gap in PSCI
-
Apr 2, 2026, 14:18Abdul Mannan: Free Warfarin and Thrombosis Management Tool for Clinicians